Frontal lobe dysfunction in secondary depression.

Depression is common in patients with neurological disease, particularly with diseases involving the basal ganglia. Although the mechanisms of mood disorders in these patients are poorly understood, selective neural pathways affected directly and indirectly by basal ganglia injury provide a strategy for examining these patients with functional imaging techniques. Studies of regional cerebral glucose metabolism by use of positron-emission tomography are reviewed. These studies demonstrate bilateral hypometabolism of orbital-inferior prefrontal cortex and anterior temporal cortex in depressed subjects, independent of disease etiology. This pattern is similar to that seen in patients with primary unipolar depression. These findings suggest that disruption of paralimbic pathways linking frontal cortex, temporal cortex, and striatum may contribute to both primary depression and depression associated with basal ganglia disease. The findings support the evolving concept of a neuroanatomical locus for mood regulation.

[1]  R. Mayeux,et al.  Clinical and biochemical features of depression in Parkinson's disease. , 1986, The American journal of psychiatry.

[2]  A. Dray Serotonin in the basal ganglia: functions and interactions with other neuronal pathways. , 1981, Journal de physiologie.

[3]  W. Jagust,et al.  Cognitive function and regional cerebral blood flow in Parkinson's disease. , 1992, Brain : a journal of neurology.

[4]  J. Morris,et al.  The association of ventral tegmental area histopathology with adult dementia. , 1988, Archives of neurology.

[5]  I. Shoulson,et al.  Psychiatric syndromes in Huntington's disease. , 1983, The American journal of psychiatry.

[6]  J R Moeller,et al.  Regional cerebral blood flow in mood disorders. I. Comparison of major depressives and normal controls at rest. , 1990, Archives of general psychiatry.

[7]  J. Penney,et al.  Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. , 1990, The New England journal of medicine.

[8]  J. Penney,et al.  NMDA receptor losses in putamen from patients with Huntington's disease. , 1988, Science.

[9]  C. Markham,et al.  Cerebral metabolism and atrophy in huntington's disease determined by 18FDG and computed tomographic scan , 1982, Annals of neurology.

[10]  J. W. Papez A PROPOSED MECHANISM OF EMOTION , 1937 .

[11]  L. Lazarus,et al.  Frequency and presentation of depressive symptoms in patients with primary degenerative dementia. , 1987, The American journal of psychiatry.

[12]  J S Fowler,et al.  Changes in brain glucose metabolism in cocaine dependence and withdrawal. , 1991, The American journal of psychiatry.

[13]  H. Mayberg,et al.  Depression and cognitive impairment in Parkinson's disease. , 1989, Brain : a journal of neurology.

[14]  M. Raichle,et al.  A functional anatomical study of unipolar depression , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  R. J. Roberts,et al.  Neuropsychological performance in lateralized parkinsonism. , 1988, Archives of neurology.

[16]  N. Alpert,et al.  Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. , 1994, Archives of general psychiatry.

[17]  K. E. Moore,et al.  Destruction of dopaminergic nerve terminals in nucleus accumbens: Effect on d-amphetamine self-administration , 1979, Pharmacology Biochemistry and Behavior.

[18]  K. Davis,et al.  Overview: toward a dysregulation hypothesis of depression. , 1985, The American journal of psychiatry.

[19]  R. Mutani,et al.  Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: possible role of the "hedonic" dopamine synapse. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[20]  P. Fedio,et al.  Quantitative analysis of interictal behavior in temporal lobe epilepsy. , 1977, Archives of neurology.

[21]  D. Kaloupek,et al.  Poststroke depression and lesion location. An attempted replication. , 1986, Brain : a journal of neurology.

[22]  P. Goldman-Rakic,et al.  Direct and indirect pathways from the amygdala to the frontal lobe in rhesus monkeys , 1981, The Journal of comparative neurology.

[23]  Marcus E. Raichle,et al.  Regional blood flow in herniparkinsonism , 1985, Neurology.

[24]  W. Jagust,et al.  Clinical-physiologic correlates of Alzheimer's disease and frontal lobe dementia. , 1989, American journal of physiologic imaging.

[25]  A. Phillips,et al.  The role of dopamine in maintaining intracranial self-stimulation in the ventral tegmentum, nucleus accumbens, and medial prefrontal cortex. , 1978, Canadian journal of psychology.

[26]  W. Nauta,et al.  Afferent and efferent relationships of the basal ganglia. , 1984, Ciba Foundation symposium.

[27]  D. Bear Hemispheric specialization and the neurology of emotion. , 1983, Archives of neurology.

[28]  B. Reisberg,et al.  Positron emission tomography in dementia. , 1983, Advances in neurology.

[29]  J. Schildkraut,et al.  The catecholamine hypothesis of affective disorders: a review of supporting evidence. , 1965, The American journal of psychiatry.

[30]  Van Praag Hm Serotonin precursors in the treatment of depression. , 1982 .

[31]  R G Robinson,et al.  Comparison of cortical and subcortical lesions in the production of poststroke mood disorders. , 1987, Brain : a journal of neurology.

[32]  Karl J. Friston,et al.  Regional cerebral blood flow abnormalities in depressed patients with cognitive impairment. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[33]  T Jones,et al.  Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease , 1985, Neurology.

[34]  H N Wagner,et al.  Paralimbic hypoperfusion in unipolar depression. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  R. Mindham Psychiatric symptoms in Parkinsonism. , 1970, Journal of neurology, neurosurgery, and psychiatry.

[36]  R. Hichwa,et al.  Positron emission tomographic scan investigations of Huntington's disease: Cerebral metabolic correlates of cognitive function , 1988, Annals of neurology.

[37]  G. Sedvall,et al.  Imaging of neurotransmitter receptors in the living human brain. , 1986, Archives of general psychiatry.

[38]  S. Yudofsky Parkinson's disease, depression, and electroconvulsive therapy: a clinical and neurobiologic synthesis. , 1979, Comprehensive psychiatry.

[39]  R. Frackowiak,et al.  Quantitative Measurement of Regional Cerebral Blood Flow and Oxygen Metabolism in Man Using 15O and Positron Emission Tomography: Theory, Procedure, and Normal Values , 1980, Journal of computer assisted tomography.

[40]  M. Cassell,et al.  Topography of projections from the medial prefrontal cortex to the amygdala in the rat , 1986, Brain Research Bulletin.

[41]  Y Agid,et al.  Is the mesocortical dopaminergic system involved in Parkinson disease? , 1980, Neurology.

[42]  C D Marsden,et al.  Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography , 1986, Movement disorders : official journal of the Movement Disorder Society.

[43]  W. Weiner,et al.  Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[44]  C. Nemeroff Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal. , 1989, The Journal of clinical psychiatry.

[45]  T. Dening,et al.  Wilson's disease. Psychiatric symptoms in 195 cases. , 1989, Archives of general psychiatry.

[46]  Ferrell Rb,et al.  Multiple sclerosis--presenting as depressive illness. , 1977 .

[47]  M. Buyse,et al.  Reproducibility of monoamine metabolite measurements in human cerebrospinal fluid , 1990, Acta neurologica Scandinavica.

[48]  J. Moossy,et al.  Neurochemical correlates of major depression in primary dementia. , 1990, Archives of neurology.

[49]  J. Cummings,et al.  Noncognitive neuropsychiatric syndromes in alzheimer’s disease , 1990 .

[50]  H. E. Rosvold,et al.  Analysis of the delayed-alternation deficit produced by dorsolateral prefrontal lesions in the rhesus monkey. , 1971, Journal of comparative and physiological psychology.

[51]  Hervé Simon,et al.  Efferents and afferents of the ventral tegmental-A10 region studied after local injection of [3H]leucine and horseradish peroxidase , 1979, Brain Research.

[52]  Pierre Fler-Henry Psychosis and temporal lobe epilepsy , 1966 .

[53]  J. Korf,et al.  Dopamine metabolism in depressions, psychoses, and Parkinson's disease: the problem of the specificity of biological variables in behaviour disorders , 1975, Psychological Medicine.

[54]  S. Iversen,et al.  Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum , 1975, Brain Research.

[55]  R. Mendius,et al.  Depression and Anxiety in Complex Partial Seizures , 1984, The Journal of nervous and mental disease.

[56]  B Mazoyer,et al.  Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions. A neuropsychological, magnetic resonance imaging and positron tomography study. , 1989, Brain : a journal of neurology.

[57]  H. Herzog,et al.  Cerebral glucose consumption measured by PET in patients with and without psychiatric symptoms of Huntington's disease , 1989, Psychiatry Research.

[58]  W. Nauta The problem of the frontal lobe: a reinterpretation. , 1971, Journal of psychiatric research.

[59]  H. E. Rosvold,et al.  Behavioral effects of selective ablation of the caudate nucleus. , 1967, Journal of comparative and physiological psychology.

[60]  A J Rush,et al.  Diagnosis and neuroanatomical correlates of depression in brain-damaged patients. Implications for a neurology of depression. , 1981, Archives of general psychiatry.

[61]  G. E. Alexander,et al.  Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. , 1990, Progress in brain research.

[62]  M. Hayden,et al.  Positron emission tomography in the early diagnosis of Huntington's disease , 1986, Neurology.

[63]  R Harrop,et al.  Cerebral Glucose Metabolism in Parkinson’s Disease , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[64]  H. Fibiger The Neurobiological Substrates of Depression in Parkinson’s Disease: A Hypothesis , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[65]  J. Mendelson,et al.  A comparison of brain perfusion SPECT in cocaine abuse and AIDS dementia complex. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[66]  Y. Agid,et al.  Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease , 1983, Brain Research.

[67]  J. Saint-Cyr,et al.  Idiopathic Parkinson's disease: Revised Concepts of Cognitive and Affective Status , 1988, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[68]  M S Buchsbaum,et al.  Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. , 1986, Journal of affective disorders.

[69]  L. Sokoloff,et al.  Localization of Functional Activity in the Central Nervous System by Measurement of Glucose Utilization with Radioactive Deoxyglucose , 1981, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[70]  Peter Herscovitch,et al.  A focal brain abnormality in panic disorder, a severe form of anxiety , 1984, Nature.

[71]  J. Saint-Cyr,et al.  Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow. , 1986, Brain : a journal of neurology.

[72]  R. Mayeux,et al.  The relationship of serotonin to depression in Parkinson's disease , 1988, Movement disorders : official journal of the Movement Disorder Society.

[73]  S. Folstein,et al.  Huntington's disease as a model for mood disorders. Clues from neuropathology and neurochemistry. , 1990, Molecular and chemical neuropathology.

[74]  Karl J. Friston,et al.  The anatomy of melancholia – focal abnormalities of cerebral blood flow in major depression , 1992, Psychological Medicine.

[75]  L. Price,et al.  Serotonergic dysfunction in depression associated with Parkinson's disease , 1992, Neurology.

[76]  M. Myslobodsky,et al.  Does unilateral dopamine deficit contribute to depression? , 1985, Psychiatry Research.

[77]  Mario F. Mendez,et al.  Neurobehavioral changes associated with caudate lesions , 1989, Neurology.

[78]  A. Coppen,et al.  Levodopa and L-tryptophan therapy in Parkinsonism. , 1972, Lancet.

[79]  M. Albert,et al.  The `subcortical dementia' of progressive supranuclear palsy , 1974, Journal of neurology, neurosurgery, and psychiatry.

[80]  R. Mayeux,et al.  Coexisting dementia and depression in Parkinson's disease. , 1989, Archives of neurology.

[81]  J. Cummings Depression and Parkinson's disease: a review. , 1992, The American journal of psychiatry.

[82]  K. Jellinger,et al.  Overview of morphological changes in Parkinson's disease. , 1987, Advances in neurology.

[83]  J M Hoffman,et al.  Clinical application of PET for the evaluation of brain tumors. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[84]  S. Pappatà,et al.  Left prefrontal glucose hypometabolism in the depressed state: a confirmation. , 1990, The American journal of psychiatry.

[85]  W. Matthews Multiple sclerosis presenting with acute remitting psychiatric symptoms. , 1979, Journal of neurology, neurosurgery, and psychiatry.

[86]  A. Alavi,et al.  The [18F]Fluorodeoxyglucose Method for the Measurement of Local Cerebral Glucose Utilization in Mane , 1979, Circulation research.

[87]  J. Coyle,et al.  Decreased receptor-binding sites for kainic acid in brains of patients with Huntington's disease. , 1981, Biological psychiatry.

[88]  A J Lees,et al.  Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness. An experimental study. , 1987, Brain : a journal of neurology.

[89]  E. Hoffman,et al.  Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method , 1979, Annals of neurology.

[90]  A. Hietaharju,et al.  Nervous system manifestations in Sjögren's syndrome , 1990, Acta neurologica Scandinavica.

[91]  T. Budinger,et al.  Evaluation of Blood — Brain Barrier Permeability Changes in Rhesus Monkeys and Man Using 82Rb and Positron Emission Tomography , 1981, Journal of computer assisted tomography.

[92]  G. Aghajanian,et al.  Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. , 1990, Archives of general psychiatry.

[93]  J. Mendlewicz,et al.  Regional Cerebral Blood Flow in Patients with Affective Disorders , 1990, British Journal of Psychiatry.

[94]  S. Folstein,et al.  The association of affective disorder with Huntington's Disease in a case series and in families , 1983, Psychological Medicine.

[95]  W. Lishman,et al.  Brain Damage in Relation to Psychiatric Disability After Head Injury , 1968, British Journal of Psychiatry.

[96]  T. Chase,et al.  Release of [3H]dopamine byl-5-hydroxytryptophan , 1972 .

[97]  R. Robinson,et al.  Specificity of affective and autonomic symptoms of depression in Parkinson's disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[98]  J. Mazziotta,et al.  Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. , 1988, The American journal of psychiatry.

[99]  R. Hichwa,et al.  PET scan investigations of Huntington's disease: Cerebral metabolic correlates of neurological features and functional decline , 1986, Annals of neurology.

[100]  R. Robinson,et al.  Mood disorders in stroke patients. Importance of location of lesion. , 1984, Brain : a journal of neurology.

[101]  G L Wolf,et al.  Brain imaging abnormalities in mental disorders of late life. , 1990, Archives of neurology.

[102]  M. Trimble,et al.  Phenomenology of Depression in Epilepsy , 1987, Epilepsia.

[103]  Judith M. Rumsey,et al.  Cerebral glucose metabolism in adults with hyperactivity of childhood onset. , 1990 .

[104]  J. Andersen,et al.  Anti‐depressive treatment in Parkinson's disease A CONTROLLED TRIAL OF THE EFFECT OF NORTRIPTYLINE IN PATIENTS WITH PARKINSON'S DISEASE TREATED WITH L‐DOPA , 1980, Acta neurologica Scandinavica.

[105]  P. Stark,et al.  A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder. , 1985, The Journal of clinical psychiatry.

[106]  H. Weingartner,et al.  The effects of lateralized frontal lesions on mood regulation. , 1986, Brain : a journal of neurology.

[107]  J S Fowler,et al.  Decreased brain metabolism in neurologically intact healthy alcoholics. , 1992, The American journal of psychiatry.

[108]  L. Altshuler,et al.  Depression, anxiety, and temporal lobe epilepsy. Laterality of focus and symptoms. , 1990, Archives of neurology.

[109]  M. Ichise,et al.  Technetium-99m-HMPAO SPECT, CT and MRI in the evaluation of patients with chronic traumatic brain injury: a correlation with neuropsychological performance. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[110]  H. Mayberg,et al.  Depression in Parkinson's disease: a biochemical and organic viewpoint. , 1995, Advances in neurology.

[111]  Karl J. Friston,et al.  Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions , 1993, Psychological Medicine.

[112]  G. Paulson,et al.  Neuropsychological Similarities in Lateralized Parkinsonism , 1989, Cortex.

[113]  H N Wagner,et al.  Mania after brain injury: Neuroradiological and metabolic findings , 1990, Annals of neurology.

[114]  G. Gainotti Emotional behavior and hemispheric side of the lesion. , 1972, Cortex; a journal devoted to the study of the nervous system and behavior.

[115]  E. Metter,et al.  Subcortical structures in aphasia. An analysis based on (F-18)-fluorodeoxyglucose, positron emission tomography, and computed tomography. , 1988, Archives of neurology.

[116]  M. Devous,et al.  Functional brain SPECT: the emergence of a powerful clinical method. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[117]  J. Baron Depression of Energy Metabolism in Distant Brain Structures: Studies with Positron Emission Tomography in Stroke Patients , 1989, Seminars in neurology.

[118]  G. E. Alexander,et al.  Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.

[119]  David E. Kuhl,et al.  Journal of Cerebral Blood Flow and Metabolism Cerebral Metabolic Relationships for Selected Brain Regions in Alzheimer's, Huntington's, and Parkinson's Diseases , 2022 .

[120]  G. Alexopoulos,et al.  Dissociation of motor response from mood and cognition in a Parkinsonian patient treated with ECT , 1985, Biological Psychiatry.

[121]  D Comar,et al.  Noninvasive tomographic study of cerebral blood flow and oxygen metabolism in vivo. Potentials, limitations, and clinical applications in cerebral ischemic disorders. , 1981, European neurology.

[122]  M S Buchsbaum,et al.  The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. , 1990, Schizophrenia bulletin.

[123]  Joseph B. Martin,et al.  Neuropeptides in neurological disease , 1986, Annals of neurology.

[124]  R G Robinson,et al.  Differential mood changes following basal ganglia vs thalamic lesions. , 1988, Archives of neurology.

[125]  R. Mayeux,et al.  Depression, intellectual impairment, and Parkinson disease , 1981, Neurology.

[126]  P. Goldman-Rakic,et al.  Topography of Corticostriatal Projections in Nonhuman Primates and Implications for Functional Parcellation of the Neostriatum , 1986 .

[127]  K. Welch,et al.  Disordered neurotransmitter function. Demonstration by measurement of norepinephrine and 5-hydroxytryptamine in CSF of patients with recent cerebral infarction. , 1974, Brain : a journal of neurology.

[128]  N. Geschwind,et al.  Hemispheric asymmetry in the expression of positive and negative emotions. Neurologic evidence. , 1982, Archives of neurology.

[129]  H. Mayberg,et al.  Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease , 1990, Annals of neurology.

[130]  R. Omdal,et al.  Clinical neuropsychiatric and neuromuscular manifestations in systemic lupus erythematosus. , 1988, Scandinavian journal of rheumatology.

[131]  J. Penney,et al.  The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.

[132]  PET-based neuropharmacology: state of the art. , 1989, Cerebrovascular and brain metabolism reviews.

[133]  W. Honer,et al.  Temporal lobe involvement in multiple sclerosis patients with psychiatric disorders. , 1987, Archives of neurology.

[134]  R. Ferrante,et al.  Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.

[135]  R. Gur,et al.  Laterality and frontality of cerebral blood flow and metabolism in schizophrenia: Relationship to symptom specificity , 1989, Psychiatry Research.

[136]  S. Folstein,et al.  Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease , 1992, Neurology.

[137]  C D Marsden,et al.  Depression in Parkinson's disease: a quantitative and qualitative analysis. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[138]  R G Robinson,et al.  Depression in Parkinson's Disease , 1990, The Journal of nervous and mental disease.

[139]  E. Azmitia,et al.  The primate serotonergic system: a review of human and animal studies and a report on Macaca fascicularis. , 1986, Advances in neurology.

[140]  R. S. Williams,et al.  Morphometric analysis of the prefrontal cortex in Huntington's disease , 1991, Neurology.

[141]  R G Robinson,et al.  Two-year longitudinal study of post-stroke mood disorders: dynamic changes in correlates of depression at one and two years. , 1987, Stroke.

[142]  L. DeLisi,et al.  Glucose utilization in the temporal cortex of affectively ill patients: Positron emission tomography , 1987, Biological Psychiatry.

[143]  D E Kuhl,et al.  Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method , 1984, Annals of neurology.

[144]  L. Berg,et al.  Preliminary report on affective symptoms in the early stages of senile dementia of the Alzheimer type. , 1983, The American journal of psychiatry.

[145]  D L Price,et al.  Parkinson's disease , 1985, Neurology.

[146]  J. Mazziotta,et al.  Reduction of prefrontal cortex glucose metabolism common to three types of depression. , 1989, Archives of general psychiatry.

[147]  Y Agid,et al.  Biochemistry of Parkinson's disease 28 years later: A critical review , 1989, Movement disorders : official journal of the Movement Disorder Society.

[148]  R. Wise Catecholamine theories of reward: A critical review , 1978, Brain Research.

[149]  A. Damasio,et al.  Severe disturbance of higher cognition after bilateral frontal lobe ablation , 1985, Neurology.